Biocatalyst Market Report 2026

The biocatalyst market size has grown strongly in recent years. It will grow from $0.6 billion in 2025 to $0.64 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to growth in pharmaceutical r&d, enzyme based food processing, industrial biochemistry adoption, environmental remediation needs, agricultural productivity demand.

The biocatalyst market size is expected to see strong growth in the next few years. It will grow to $0.82 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to precision medicine growth, green chemistry adoption, biofuel expansion, enzyme engineering advances, sustainable manufacturing demand. Major trends in the forecast period include growing use of enzymes in pharmaceutical production, increasing adoption in sustainable chemical processes, expansion of biocatalysts in biofuel production, rising demand for high specificity catalysts, focus on process efficiency and yield optimization.

The rising shift toward natural food products is expected to propel the growth of the biocatalyst market going forward. Natural food products are produced without synthetic chemicals, pesticides, or genetically modified organisms (GMOs) and are minimally processed with no artificial additives. Demand for these products is increasing due to growing consumer health consciousness and the need for greater transparency in the food supply chain. Biocatalysts, including enzymes, support the production of natural food products by facilitating biochemical reactions that improve fermentation, enhance flavor, and support preservation. For example, in May 2023, the Organic Trade Association reported that total organic sales - including non-food products - reached $60 billion in 2022 and surged to a record $67.6 billion in 2023, highlighting substantial growth in the organic market. Therefore, the rising preference for natural food products is driving the expansion of the biocatalyst market.

Major companies in the biocatalyst market are focusing on developing advanced solutions such as nucleases to improve the efficiency of biotechnological processes and lower manufacturing costs across industries. A nuclease is an enzyme that acts as a biocatalyst by catalyzing the hydrolysis of phosphodiester bonds in nucleic acids such as DNA and RNA, breaking them down into smaller components. For instance, in March 2023, Biocatalysts Ltd., a UK-based biotechnology research company, introduced Nuclease 46L (N046L), an enzyme designed to degrade various nucleic acids from multiple sources. This solution provides a cost-effective approach to DNA elimination in biotechnology applications by reducing nucleic acid content, improving downstream processing efficiency, and helping ensure final food products are free from nucleic acid residues.

In May 2023, BRAIN Biotech AG, a Germany-based industrial biotechnology company, acquired Biocatalysts Ltd. for an undisclosed amount. The acquisition enables BRAIN Biotech to consolidate its industrial production capabilities and establish a dedicated bioproducts segment, generating revenue and cost synergies. This strategic move supports the company’s growth objectives and helps streamline organizational structures, particularly within the product-focused business unit. Biocatalysts Ltd. is a UK-based biotechnology research company specializing in innovative enzyme solutions for various industrial applications.

Major companies operating in the biocatalyst market are BASF SE, F. Hoffmann-La Roche AG, Evonik Industries AG, Koninklijke DSM N.V., Novozymes A/S, Chr. Hansen Holding A/S, Piramal Pharma Solutions, Ginkgo Bioworks Inc., Codexis Inc., BBI Solutions, AB Enzymes GmbH, BRAIN Biotech AG, DuPont Industrial Biosciences, Amano Enzyme Inc., Biosynth Carbosynth AG, BioCat GmbH, Enzyme Development Corporation, Prozomix Limited, evoxx technologies GmbH, Enzymicals AG, Dyadic International Inc., Advanced Enzyme Technologies Ltd., Creative Enzymes, Direvo Industrial Biotechnology GmbH.

North America was the largest region in the biocatalyst market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biocatalyst market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biocatalyst market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biocatalyst market consists of sales of industrial enzymes, specialty enzymes, enzyme kits, and immobilized enzymes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.